Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 12,800 shares at $0.08 ($51K) on 2024-08-19, disclosed to the SEC on 2024-08-20.
Open-market purchase of $51k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 6,400 | $508 | 1.0% |
| 2 | $7.93 | 6,400 | $51K | 99.0% |
| Total | $4.00 avg | 12,800 | $51K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |